{"name":"CHARTWELL RX","slug":"chartwell-rx","ticker":"","exchange":"","domain":"chartwellrx.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ACETIC ACID","genericName":"ACETIC ACID, GLACIAL","slug":"acetic-acid-glacial","indication":"Otitis externa","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"FULVICIN P/G 330","genericName":"GRISEOFULVIN, ULTRAMICROSIZE","slug":"griseofulvin-ultramicrosize","indication":"Onychomycosis due to dermatophyte","status":"marketed"}]}],"pipeline":[{"name":"ACETIC ACID","genericName":"ACETIC ACID, GLACIAL","slug":"acetic-acid-glacial","phase":"marketed","mechanism":"Free fatty acid receptor 3, Tyrosine-protein kinase Fyn, Tyrosine-protein kinase Lck","indications":["Otitis externa"],"catalyst":""},{"name":"FULVICIN P/G 330","genericName":"GRISEOFULVIN, ULTRAMICROSIZE","slug":"griseofulvin-ultramicrosize","phase":"marketed","mechanism":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","indications":["Onychomycosis due to dermatophyte","Tinea barbae","Tinea capitis","Tinea corporis","Tinea cruris"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}